![PRD_002425 PRD_002425](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002425.svg) | PRD_002425 | Name: | Drosocin | Formula: | C98 H166 N34 O24 | Definition date: | 2023-03-08 | Last modified: | 2023-03-08 |
|
![PRD_002526 PRD_002526](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002526.svg) | PRD_002526 | Name: | DFFR-chloromethyl ketone inhibitor | Formula: | C25 H34 N6 O3 | Definition date: | 2023-02-22 | Last modified: | 2023-02-22 |
|
![PRD_002512 PRD_002512](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002512.svg) | PRD_002512 | Name: | all-D Helicon Polypeptide FP40914 | Formula: | C92 H114 N20 O22 S2 | Definition date: | 2023-02-15 | Last modified: | 2023-02-15 |
|
![PRD_002513 PRD_002513](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002513.svg) | PRD_002513 | Name: | all-D Helicon Polypeptide FP40926 | Formula: | C86 H116 N22 O24 S3 | Definition date: | 2023-02-15 | Last modified: | 2023-02-15 |
|
![PRD_002514 PRD_002514](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002514.svg) | PRD_002514 | Name: | an all-D Helicon Polypeptide FP40927 | Formula: | C81 H122 N19 O21 S2 | Definition date: | 2023-02-15 | Last modified: | 2023-02-15 |
|
![PRD_002515 PRD_002515](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002515.svg) | PRD_002515 | Name: | all-D Helicon Polypeptide FP40918 | Formula: | C84 H115 N22 O26 S2 | Definition date: | 2023-02-15 | Last modified: | 2023-02-15 |
|
![PRD_002424 PRD_002424](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002424.svg) | PRD_002424 | Name: | Darobactin 22 | Formula: | C53 H67 N15 O11 | Definition date: | 2023-01-11 | Last modified: | 2023-01-11 |
|
![PRD_002430 PRD_002430](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002430.svg) | PRD_002430 | Name: | Darobactin 9 | Formula: | C49 H57 N12 O12 | Definition date: | 2023-01-11 | Last modified: | 2023-01-11 |
|
![PRD_002411 PRD_002411](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002411.svg) | PRD_002411 | Name: | peptide BOC-GLY-PHE-HIS-H | Formula: | C22 H30 N5 O5 | Definition date: | 2022-12-07 | Last modified: | 2022-12-07 |
|
![PRD_002412 PRD_002412](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002412.svg) | PRD_002412 | Name: | peptide OCA-GLY-PHE-HIS-H | Formula: | C25 H36 N5 O4 | Definition date: | 2022-12-07 | Last modified: | 2022-12-07 |
|
![PRD_002413 PRD_002413](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002413.svg) | PRD_002413 | Formula: | C19 H24 N5 O4 | Definition date: | 2022-11-30 | Last modified: | 2022-11-30 |
|
![PRD_002043 PRD_002043](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002043.svg) | PRD_002043 | Name: | Goblin1 | Formula: | C34 H60 N8 O12 | Definition date: | 2013-12-04 | Last modified: | 2022-10-29 |
|
![PRD_002086 PRD_002086](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002086.svg) | PRD_002086 | Formula: | C24 H34 N4 O8 | Definition date: | 2013-10-02 | Last modified: | 2022-10-29 |
|
![PRD_002409 PRD_002409](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002409.svg) | PRD_002409 | Name: | UDP-MurNAc-pentapeptide | Formula: | C37 H58 N8 O26 P2 S | Description: | Peptidoglycan precursor analogue | Definition date: | 2022-10-26 | Last modified: | 2022-10-26 |
|
![PRD_002097 PRD_002097](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002097.svg) | PRD_002097 | Name: | [[[(4S)-5-[[(2S)-1-[[(2S)-5-[[azaniumylidene(azanyl)methyl]amino]-1-oxidanylidene-pentan-2-yl]amino]-3-methyl-1-oxidanylidene-butan-2-yl]amino]-5-oxidanylidene-4-[[(2S)-1-oxidanyl-1-oxidanylidene-3-phenyl-propan-2-yl]carbamoylamino]pentyl]amino]-azanyl-methylidene]azanium | Formula: | C27 H46 N10 O6 | Description: | Acts as a reversible inhibitor of serine/cysteine proteases and some trypsin-like serine proteases. | Definition date: | 2013-08-07 | Last modified: | 2022-10-20 |
|
![PRD_002471 PRD_002471](https://data.pdbj.org/pdbjplus/data/cc/svg/YVP.svg) | PRD_002471 | Name: | N-{3-[(prop-2-yn-1-yl)oxy]propanoyl}-D-phenylalanyl-N-[(3S)-6-carbamimidamido-2-oxohexan-3-yl]-L-phenylalaninamide | Formula: | C31 H40 N6 O5 | Definition date: | 2022-10-12 | Last modified: | 2022-10-12 |
|
![PRD_002472 PRD_002472](https://data.pdbj.org/pdbjplus/data/cc/svg/YVY.svg) | PRD_002472 | Name: | N-{3-[(prop-2-yn-1-yl)oxy]propanoyl}-D-phenylalanyl-N-[(3S)-6-(carbamoylamino)-2-oxohexan-3-yl]-L-phenylalaninamide | Formula: | C31 H39 N5 O6 | Definition date: | 2022-10-12 | Last modified: | 2022-10-12 |
|
![PRD_002370 PRD_002370](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002370.svg) | PRD_002370 | Name: | Taltirelin | Formula: | C17 H24 N7 O5 | Definition date: | 2022-08-31 | Last modified: | 2022-08-31 |
|
![PRD_002371 PRD_002371](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002371.svg) | PRD_002371 | Name: | Endogenous Peptide Agonist TRH | Formula: | C16 H23 N6 O4 | Definition date: | 2022-08-31 | Last modified: | 2022-08-31 |
|
![PRD_002496 PRD_002496](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002496.svg) | PRD_002496 | Name: | evybactin | Formula: | C64 H91 N21 O21 | Definition date: | 2022-08-17 | Last modified: | 2022-08-17 |
|
![PRD_002491 PRD_002491](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002491.svg) | PRD_002491 | Name: | Sa-D2 | Formula: | C88 H122 N19 O23 S2 | Definition date: | 2022-08-10 | Last modified: | 2022-08-10 |
|
![PRD_002492 PRD_002492](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002492.svg) | PRD_002492 | Name: | Sa-D3 | Formula: | C87 H110 N18 O24 S | Definition date: | 2022-08-10 | Last modified: | 2022-08-10 |
|
![PRD_002367 PRD_002367](https://data.pdbj.org/pdbjplus/data/cc/svg/5R3.svg) | PRD_002367 | Name: | ~{N}-[3-[3-(dimethylamino)propylamino]-3-oxidanylidene-propyl]-1-methyl-4-[3-[[1-methyl-4-[[1-methyl-4-[3-[[1-methyl-4-[(1-methylimidazol-2-yl)carbonylamino]pyrrol-2-yl]carbonylamino]propanoylamino]imidazol-2-yl]carbonylamino]pyrrol-2-yl]carbonylamino]propanoylamino]imidazole-2-carboxamide | Formula: | C41 H55 N17 O8 | Definition date: | 2022-08-03 | Last modified: | 2022-08-03 |
|
![PRD_002384 PRD_002384](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002384.svg) | PRD_002384 | Formula: | C58 H95 N15 O15 | Definition date: | 2022-08-03 | Last modified: | 2022-08-03 |
|
![PRD_002495 PRD_002495](https://data.pdbj.org/pdbjplus/data/cc/svg/K36.svg) | PRD_002495 | Name: | (1S,2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid | Formula: | C21 H31 N3 O8 S | Definition date: | 2022-05-04 | Last modified: | 2022-05-04 |
|